Diabetes patients worry about insulin shortages as Ozempic use skyrockets
The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...
As insulin shortages persist, what diabetes patients can do
Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...
$35 insulin: Who in the US benefits?
Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...
Explainer-Who in the US Benefits From $35 Insulin?
Nearly one-third of those patients were paying $35 or far more per month in 2019, according to the latest available data from ...
Detroit Free Press12d
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
Three drug companies dominate the U.S. insulin market: Novo Nordisk, Eli Lilly and Sanofi. Last spring, Eli Lilly reported its drugs Humalog and insulin lispro were in short supply. Novo Nordisk ...